BCR-ABL Quantitative (International Scale) Gene Fusions in Varanasi

BCR-ABL quantitative (International Scale) gene fusions is a genetic test performed on the blood or bone marrow sample that helps to detect and quantitate BCR-ABL1 fusion in different types of leukemias (blood cancer) chronic myeloid Leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML). BCR-ABL1 is a fusion product of two genes BCR and ABL1 and the number of copies of fused gene is important to understand disease and the treatment efficacy.. This test uses an international scale to measure the number of BCR-ABL gene. In individuals with certain types of leukemia, this fusion gene is overactive and causes the development and progression of the cancer. This test can help your doctor track how well your treatment is working and whether adjustments need to be made.

Note: Genetic counseling can be provided. If interested, please send the request to this email id:[email protected]